We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CureVac Goes After BioNTech Claiming Patent Infringement by Comirnaty’s mRNA Underpinnings
CureVac Goes After BioNTech Claiming Patent Infringement by Comirnaty’s mRNA Underpinnings
CureVac has filed a patent infringement lawsuit against BioNTech, claiming its messenger RNA (mRNA) technology was used without credit or compensation to create BioNTech’s and Pfizer’s Comirnaty, the world’s first approved COVID-19 vaccine and now the most widely used one.